MedTrace Logo

Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms

NCT07686198 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-07-07

No results posted yet for this study

Summary

The primary objective is to compare Re-Q Pro-Longevity serum versus vehicle serum combined with Intense Pulsed Laser for the treatment of moderate to severe photodamage and crepiness on the dorsal forearms.

Conditions

  • Photodamaged Skin

Interventions

DRUG

Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy

Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy

DRUG

Left Arm treated with vehicle serum and Intense Pulsed Light Therapy

Left Arm treated with vehicle serum and Intense Pulsed Light Therapy

Sponsors & Collaborators

  • Rapalogix

    collaborator UNKNOWN

  • Goldman, Butterwick, Fitzpatrick and Groff

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-10
Primary Completion
2026-11-10
Completion
2027-01-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07686198 on ClinicalTrials.gov